Brief: Amphastar Pharmaceuticals Enters Contract Research Agreement With Hanxin -SEC Filing
18/09/2025 21:55
Sept 18 (Reuters) - SEC Filing: AMPHASTAR PHARMACEUTICALS INC - ON SEPT 15, ENTERS CONTRACT RESEARCH AGREEMENT WITH HANXIN - SEC FILING Source text: [ID:n0001297184-25-000054] Further company coverage: AMPH.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Amphastar Pharmaceuticals,
See all newsU.S. RESEARCH ROUNDUP-Airbnb, HII, Tesla
Amphastar Q1 revenue and adjusted EPS miss estimates
Brief: Amphastar Pharmaceuticals Q1 EPS USD 0.14
Brief: Amphastar Pharmaceuticals Inc - Authorizes $50 Million Increase To Share Buyback Program On March 12, 2026 - SEC Filing
Brief: Amphastar Pharmaceuticals- Nanjing Pharmaceuticals Enters Supply Agreement With Nanjing Letop Biotechnology On March 3 - SEC Filing